Table 2.
Comparison of major renal transplant outcomes among various patient groups.
| US [31, 32] (cadaveric /living) (All etiologies) | Europe [31, 32] (cadaveric /living) (All etiologies) | Our cohort (AL amyloidosis) | USRDS 2017 [33] (All types of amyloidosis) | >65 yrs US (cadaveric/ living) [31, 32] (All etiologies) | DM US (cadaveric /living) [31, 32] (All etiologies) | ||
|---|---|---|---|---|---|---|---|
| Number of patients | 237 | 576 | |||||
| Overall survival (years from renal Tx) | Median | N/A | N/A | 8.6 | 5.8 | N/A | N/A |
| 1 yr | 97%/98.7% | 96%/98% | 95% | 91% | 94.2%/96% | 96%/97% | |
| 3 yrs | N/A | N/A | 83% | N/A | 86%/89.5% | 89%/93% | |
| 5 yrs | 86%/93% | 87%/94% | 74% | 70% | 73.9%/82% | 83%/87% | |
| Graft survival (years) | Median | 9.1 | 7.8 | 4.8 | |||
| 1 yr | 93.4%/97.2% | 90.7%/95.8% | 92% | N/A | 89%/94% | 92%/96% | |
| 3 yrs | N/A | N/A | 79% | N/A | 80%/87% | 83%/88.5% | |
| 5 yrs | 72.4%/84.6% | 77.8%/86.9% | 69% | N/A | 70%/78% | 73%/81.5% |
USRDS The United States Renal Data System, DM diabetes mellitus, N/A not applicable.